The results showed that the expression of CDR1as was negatively correlated with the efficacy of neoadjuvant chemotherapy in breast cancer patients (P < 0.05) (Figure 1B), indicating that the lower the expression of CDR1as, the better the effect of chemotherapy. The gene discussed is LINC00632; the disease is breast carcinoma.